Testing effectiveness (Phase 2)Study completedNCT05785442
What this trial is testing
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
Who this might be right for
Community-acquired PneumoniaHospital-acquired Pneumonia
Hellenic Institute for the Study of Sepsis 60